Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
498
-
Total 13F shares, excl. options
-
44.3M
-
Shares change
-
+125K
-
Total reported value, excl. options
-
$12.3B
-
Value change
-
+$52.9M
-
Put/Call ratio
-
0.85
-
Number of buys
-
238
-
Number of sells
-
-196
-
Price
-
$278.09
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q4 2022
550 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q4 2022.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 498 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.3M shares
of 44.8M outstanding shares and own 98.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.51M shares), VANGUARD GROUP INC (4.48M shares), Avoro Capital Advisors LLC (2.87M shares), FMR LLC (2.59M shares), WELLINGTON MANAGEMENT GROUP LLP (2.57M shares), RENAISSANCE TECHNOLOGIES LLC (2.34M shares), STATE STREET CORP (1.55M shares), Avidity Partners Management LP (786K shares), JANUS HENDERSON GROUP PLC (767K shares), and GEODE CAPITAL MANAGEMENT, LLC (661K shares).
This table shows the top 498 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.